MoneyWorks4Me

Zenotech Laboratorie - Quaterly Results

29 Apr 2022 Evaluate
The revenue zoomed 7.22% to Rs. 84.18 millions for the quarter ended March 2022 as compared to Rs. 78.51 millions during the corresponding quarter last year.The Total revenue for the quarter ended March 2022 of  Rs. 141.20  millions  grew by 1096.61% from Rs. 11.80 millions.Operating profit for the quarter ended March 2022 rose to 37.21 millions as compared to 33.76 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 84.18 78.51 7.22 365.65 224.45 62.91 365.65 224.45 62.91
Other Income 4.92 3.39 45.13 6.29 4.08 54.17 6.29 4.08 54.17
PBIDT 37.21 33.76 10.22 180.90 67.89 166.46 180.90 67.89 166.46
Interest 1.48 4.58 -67.69 12.15 15.48 -21.51 12.15 15.48 -21.51
PBDT 35.73 29.18 22.45 168.75 52.41 221.98 168.75 52.41 221.98
Depreciation 17.28 17.38 -0.58 69.74 64.56 8.02 69.74 64.56 8.02
PBT 18.45 11.80 56.36 99.01 -12.15 -914.90 99.01 -12.15 -914.90
TAX -122.75 0.00 0.00 -122.75 0.00 0.00 -122.75 0.00 0.00
Deferred Tax -122.75 0.00 0.00 -122.75 0.00 0.00 -122.75 0.00 0.00
PAT 141.20 11.80 1096.61 221.76 -12.15 -1925.19 221.76 -12.15 -1925.19
Equity 610.31 610.31 0.00 610.31 610.31 0.00 610.31 610.31 0.00
PBIDTM(%) 44.20 43.00 2.80 49.47 30.25 63.56 49.47 30.25 63.56
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..